Eric Francois - 01 Jul 2021 Form 4 Insider Report for Diffusion Pharmaceuticals Inc. (CRVO)

Role
Director
Signature
/s/ William R. Elder, as attorney-in-fact for the Reporting Person
Issuer symbol
CRVO
Transactions as of
01 Jul 2021
Net transactions value
$0
Form type
4
Filing time
06 Jul 2021, 21:41:36 UTC
Previous filing
15 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DFFN Stock Option (Right to Buy) Award $0 +83,300 $0.000000 83,300 01 Jul 2021 Common Stock 83,300 $0.7200 Direct F1
transaction DFFN Stock Option (Right to Buy) Award $0 +83,300 $0.000000 83,300 01 Jul 2021 Common Stock 83,300 $0.7200 Direct F2
transaction DFFN Restricted Stock Unit Award $0 +69,400 $0.000000 69,400 01 Jul 2021 Common Stock 69,400 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021.
F2 The shares underlying the options will vest in 18 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over an 18-month period beginning July 1, 2021.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4 The shares underlying the restricted stock units will vest in 6 equal (or as nearly equal as possible) tri-monthly installments on the last calendar day of every third month over an 18-month period beginning on January 1, 2023.